---
title: OVCAR-8 Orthotopic Model - TD2 Precision Oncology
description: OVCAR-8 is an ovarian cancer cell line widely used for studying ovarian cancer and testing therapeutic interventions.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/ovcar-8.png
---

×

 

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

# OVCAR-8 Orthotopic Model

**Synonyms:** -

OVCAR-8 is a well-established human ovarian cancer cell line commonly used for studying ovarian cancer biology and testing therapeutic interventions. It retains characteristics of ovarian cancer, including epithelial morphology, proliferation, and genetic alterations. OVCAR-8 serves as a valuable model for investigating ovarian cancer mechanisms, evaluating drug responses, and developing novel treatment strategies. Researchers utilize this cell line to gain insights into ovarian cancer pathogenesis and explore personalized medicine approaches.

## Model Details

**Cancer Type:** Ovarian Cancer  
**Model Name:** OVCAR-8  
**Mouse Strain:** Nu/Nu  
**Treatment Data Available:** N/A

## OVCAR-8 Survival

![OVCAR-8 Orthotopic Model](https://td2inc.com/hubfs/Assets/GraphsFigures/ovcar-8.png)

Survival of IP disseminated OVCAR-8 in Nu/Nu mice (n=10 mice)

### Request Additional Syngeneic Model Data

## CONTACT US

## Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.

[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)

[![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/td2-logo.png?width=160&name=td2-logo.png)](https://td2inc.com/?hsLang=en)

Office  
13208 E. Shea Blvd,   
Suite 100   
Scottsdale, AZ 85259

Phone  
(602) 358-8300

Connect with us

- <https://www.linkedin.com/company/translational-drug-development/>
- <https://twitter.com/TD2_Oncology>

![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/Assets/Logo/acclac-logo.png?width=139&name=acclac-logo.png)

© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)